NHS England has established a “deliberative committee” to review professional leadership for the pharmacy, the chief pharmaceutical company announced.
Speaking at the Clinical Pharmacy Congress in London on May 13, 2022, David Webb, Chief Pharmacy Officer for England, said strong professional leadership is needed “to lead, support and enable the transformative change” underway for the pharmacy, including the move to allow all pharmacists to prescribe themselves at the time of registration starting in 2026.
“That is why the four UK pharmaceutical chiefs are setting up a commission to produce a briefing for the purpose and functions for professional pharmacy leadership for the future,” he said.
A slide accompanying his speech states that the commission’s purpose would be “to produce a blueprint for the purpose and functions of a professional pharmacy leadership body to best develop, support and deliver excellence in patient care and practice. professional”.
Webb added in his speech that the commission will ensure “that they have the right support in place for the profession, for the patients, for the NHS to work with the regulator and the government.”
“Not least, we will need this leadership to make sure the transition to independent prescribing is safe and effective and that everything that will make it so is in place,” he continued.
The goal for trainees to become independent prescribers upon registration was first proposed by the General Pharmaceutical Council (GPhC) and the four UK Chief Pharmaceutical Officers in July 2020, with the GPhC subsequently clarifying in the standards updated initial education and training that students starting the first year of their MPharm in 2021 would be the first cohort to become independent prescribers upon their registration in 2026.
Commenting on the announcement, the Royal Pharmaceutical Society (RPS) said it believes “strongly that the RPS is the organization capable of establishing and ensuring standards of post-registration pharmaceutical practice.”
“We have already taken a collaborative approach to develop a suite of post-registration study programs across the UK to ensure safe and effective healthcare,” said the RPS.
“We will continue to work with the GPhC and others on this development program.”
He added that the RPS is “demonstrably working across the UK to accredit consultant pharmacist posts and credentials on behalf of the NHS.”
“We are willing and able to work with pharmacy technicians to help support their professional development. We believe RPS is best placed to create an aligned framework for post-registration assessment and credentials of pharmacy technicians working in partnership with all stakeholders, including [the Association of Pharmacy Technicians UK]. “
Webb was recently appointed Chief Pharmaceutical Officer for England in February 2022, after taking over from Keith Ridge who had spent 16 years in office.